FDA 483 - AMCOL Health & Beauty Solutions, Inc DBA AMCOL Household and Personal Care - December 04, 2018
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Anco Health & Beauty Solutions, a drug manufacturer in Lafayette, LA, was inspected by the FDA, revealing several quality control deficiencies. Observations included a missing retain sample, an unidentified item lacking content or causation status, and issues with corrective and preventive action (CAPA) processes. Specifically, CAPA target dates were exceeded without proper documentation, and trial-and-error actions were conducted in the manufacturing environment with saleable products.
- Inspection Date
- December 4, 2018
- Product Type
- Drugs
ID · 84487361-ea7d-48f9-8c67-cf19566ff45b